Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIG1 hypoxia inducible domain family member 1A pseudogene 16 (HIGD1AP16) is a human pseudogene representing a non-functional duplicate of the HIGD1A gene, which encodes a mitochondrial protein involved in mitochondrial homeostasis and cellular responses to stress[8][6]. Unlike HIGD1A, HIGD1AP16 does not encode an active protein and is not considered a molecular target or receptor for pharmacological intervention. It does not have known biochemical function, clinical relevance, or associated therapeutic drugs. The use of this pseudogene as a molecular target would be incorrect, as only the functional HIGD1A protein is implicated in biological processes and disease mechanisms[8][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIG1 hypoxia inducible domain family member 1A pseudogene 16 (HIGD1AP16).